Trials / Terminated
TerminatedNCT04881253
COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 23 (actual)
- Sponsor
- Centre Hospitalier Intercommunal Creteil · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this research is to build a collection of non-invasive retinal imaging (OCT and OCTA) in order to investigate the incidence and impact of retinal damage in patients who have or have had COVID-19.
Detailed description
This monocentric study is aimed at 3 types of patients: * Those who have been hospitalized for Covid-19 during the epidemic * Newly infected and diagnosed patients Covid-19 * Those with paucisymptomatic Covid-19 who did not require hospitalisation At the patient's inclusion, an ophthalmologic assessment will be performed including : * visual acuity, * SD-OCT + multicolor, * OCT-A, * color retinography, Fundus examination, optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) in all COVID-19 patients may detect retinal lesions. In addition, if a correlation is demonstrated between clinical and paraclinical parameters and between disease severity and retinal vascular damage in non-invasive imaging (OCT and OCTA), this would allow a better understanding of the pathophysiology of the disease, as well as factors that may influence disease severity and the mechanisms potentially responsible for the observed disorders.
Conditions
Timeline
- Start date
- 2021-11-05
- Primary completion
- 2023-01-17
- Completion
- 2023-01-17
- First posted
- 2021-05-11
- Last updated
- 2025-09-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04881253. Inclusion in this directory is not an endorsement.